In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
In hematologic diseases, such as sickle cell disease (SCD) and hemolytic uremic syndrome (HUS), pathological biophysical interactions among blood cells, endothelial cells, and soluble factors lead to microvascular occlusion and thrombosis. Here, we report an in vitro "endothelialized" microfluidic microvasculature model that recapitulates and integrates this ensemble of pathophysiological processes. Under controlled flow conditions, the model enabled quantitative investigation of how biophysical alterations in hematologic disease collectively lead to microvascular occlusion and thrombosis. Using blood samples from patients with SCD, we investigated how the drug hydroxyurea quantitatively affects microvascular obstruction in SCD, an unresolved issue pivotal to understanding its clinical efficacy in such patients. In addition, we demonstrated that our microsystem can function as an in vitro model of HUS and showed that shear stress influences microvascular thrombosis/obstruction and the efficacy of the drug eptifibatide, which decreases platelet aggregation, in the context of HUS. These experiments establish the versatility and clinical relevance of our microvasculature-on-a-chip model as a biophysical assay of hematologic pathophysiology as well as a drug discovery platform.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, microfluidic devices (i.e. thrombosis-on-chip devices) are of interest to mimic a range of flows and shear stresses, starting from low (i.e. in veins) to high values (i.e. in arteries) [287–290].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [289]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These devices possess endothelialized lumen that can reliably capture several features of blood vessels such as atherosclerosis (i.e. fatty plaque deposition and formation) and bifurcations (i.e. branches and bends) by changing the channel geometries and flow patterns, ranging from laminar steady flow to pulsatile flow [287–290,295–304].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [289]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moake, J. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020528 · Cited by 1,221
Self-citationPathogenesis and Treatment of Sickle Cell Disease
Bunn, H. F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371107 · Cited by 1,154
Cell and molecular mechanics of biological materials
Bao, G., & Suresh, S. (2003) · Nature Materials · doi:10.1038/nmat1001 · Cited by 1,055
A shear gradient–dependent platelet aggregation mechanism drives thrombus formation
Nesbitt, W. S., Westein, E., Tovar-Lopez, F. J., Tolouei, E., Mitchell, A., Fu, J., Carberry, J., Fouras, A., & Jackson, S. P. (2009) · Nature Medicine · doi:10.1038/nm.1955 · Cited by 862
The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion
Granger, D. N., & Kubes, P. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.55.5.662 · Cited by 849
Vestweber (2008) · doi:10.1161/atvbaha.107.158014 · Cited by 806
Adhesion Mechanisms in Platelet Function
Ruggeri, Z. M., & Mendolicchio, G. L. (2007) · Circulation Research · doi:10.1161/01.res.0000267878.97021.ab · Cited by 755
Resistance to blood flow in microvessels in vivo.
Pries, A. R., Secomb, T. W., Gessner, T., Sperandio, M. B., Gross, J. F., & Gaehtgens, P. (1994) · Circulation Research · doi:10.1161/01.res.75.5.904 · Cited by 616
Fundamentals of microfluidic cell culture in controlled microenvironments
Young, E. W. K., & Beebe, D. J. (2010) · Chemical Society Reviews · doi:10.1039/b909900j · Cited by 615
Mechanics of Stimulated Neutrophils: Cell Stiffening Induces Retention in Capillaries
Worthen, G. S., Schwab, B., Elson, E. L., & Downey, G. P. (1989) · Science · doi:10.1126/science.2749255 · Cited by 597
Research works printed but not linked: 2
- Athanassiou, 2006, Clin Hemorheol Microcirc., 35, 291
- Reinke, 1987, Am J Physiol., 253, H540
Cited by
The present and future role of microfluidics in biomedical research
Sackmann, E. K., Fulton, A. L., & Beebe, D. J. (2014) · Nature · doi:10.1038/nature13118 · Cited by 2,995
Engineering of functional, perfusable 3D microvascular networks on a chip
Kim, S., Lee, H., Chung, M., & Jeon, N. L. (2013) · Lab on a Chip · doi:10.1039/c3lc41320a · Cited by 872
Biomechanical properties of red blood cells in health and disease towards microfluidics
Tomaiuolo, G. (2014) · Biomicrofluidics · doi:10.1063/1.4895755 · Cited by 368
Microfluidics: reframing biological enquiry
Duncombe, T. A., Tentori, A. M., & Herr, A. E. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4041 · Cited by 345
Jain, A., Barrile, R., van der Meer, A., Mammoto, A., Mammoto, T., De Ceunynck, K., Aisiku, O., Otieno, M., Louden, C., Hamilton, G., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.742 · Cited by 325
Metadata
- Authors
- Tsai, M., Kita, A., Leach, J., Rounsevell, R., Huang, J. N., Moake, J., Ware, R. E., Fletcher, D. A., & Lam, W. A.
- Affiliations
- University of California, Berkeley (US)
- Corresponding author
- Lam, Wilbur A.
- Venue
- Journal of Clinical Investigation
- Published
- 2012-01-03
- Volume
- 122
- Issue
- 1
- Pages
- 408-418
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3248292
- OpenAlex
- W2134766290
- Cited by
- 297
- References
- 58
- Citations by year
- 2026: 13 · 2025: 18 · 2024: 11 · 2023: 23 · 2022: 19 · 2021: 25 · 2020: 25 · 2019: 19 · 2018: 20 · 2017: 33 · 2016: 21 · 2015: 22 · 2014: 26 · 2013: 12 · 2012: 9
- FWCI
- 12.78
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science Foundation (CAREER)
- Emory University
- Children's Healthcare of Atlanta
- National Institutes of Health (NIH-R01)
- U.S. Public Health Service
- University of California, San Francisco
- National Heart, Lung, and Blood Institute (K08HL093360, U54HL112309)
- National Eye Institute (PN2EY018244)
- Topics
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- microvascular occlusion, thrombosis, sickle cell disease, hemolytic uremic syndrome, hydroxyurea, eptifibatide, shear stress, platelet aggregation, in vitro disease model, drug discovery
- MeSH terms
- Eptifibatide, Anemia, Sickle Cell, Hematologic Diseases, Hemolytic-Uremic Syndrome, Humans, Hydroxyurea, Microscopy, Fluorescence, Models, Cardiovascular, Peptides, Platelet Aggregation Inhibitors, Thrombosis, Hemorheology, Microfluidic Analytical Techniques, Microvessels, Human Umbilical Vein Endothelial Cells, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. https://app.cochat.ai/papers/10.1172/jci58753
- The paper
- Tsai, M., Kita, A., Leach, J., Rounsevell, R., Huang, J. N., Moake, J., Ware, R. E., Fletcher, D. A., & Lam, W. A. (2012). In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. Journal of Clinical Investigation. https://doi.org/10.1172/jci58753
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.